ConductScience.org, home

Paper41008962

Gas Plasma Combination Therapies-Promises from Preclinical Oncology Research.

Yu L and 9 others. Antioxidants (Basel), 2025. Cited by 3 papers, by iCite.

Cite this record

ConductScience Library. Gas Plasma Combination Therapies-Promises from Preclinical Oncology Research. Papers, record 41008962. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41008962

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Gas Plasma Combination Therapies-Promises from Preclinical Oncology Research.
PubMed
Journal
Antioxidants (Basel)
PubMed
Year
2025
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
3
iCite
Revised in PubMed
2025-09-30
PubMed

Authors10

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Yu LLingyun
2Berner JJuliahttps://orcid.org/0009-0006-4655-5986
3Martinet AAlice
4Freund EErichttps://orcid.org/0000-0003-2950-0984
5Singer DDeborahttps://orcid.org/0000-0003-2335-1607
6von Woedtke TThomashttps://orcid.org/0000-0002-1097-4832
7Weltmann KDKlaus-Dieterhttps://orcid.org/0000-0002-4161-205X
8Emmert SSteffenhttps://orcid.org/0000-0001-5630-4204
9Clemen RRamona
10Bekeschus SSanderhttps://orcid.org/0000-0002-8773-8862

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References263

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
138021092Non-invasive physical plasma for preventing radiation dermatitis in breast cancer: Results from an intrapatient-randomised double-blind placebo-controlled trial.Clin Transl Radiat Oncol2024https://conductscience.org/library/papers/38021092PubMed
232337527Multifunctional sonosensitizers in sonodynamic cancer therapy.Chem Soc Rev2020https://conductscience.org/library/papers/32337527PubMed
337945390The impact of NCCN-compliant multidisciplinary conference on the uptake of active surveillance among eligible patients with localized prostate cancer.Urol Oncol2023https://conductscience.org/library/papers/37945390PubMed
427268750Classification, Treatment Strategy, and Associated Drug Resistance in Breast Cancer.Clin Breast Cancer2016https://conductscience.org/library/papers/27268750PubMed
531450811Risk Assessment of kINPen Plasma Treatment of Four Human Pancreatic Cancer Cell Lines with Respect to Metastasis.Cancers (Basel)2019https://conductscience.org/library/papers/31450811PubMed
622140530Atmospheric-pressure plasma jet induces apoptosis involving mitochondria via generation of free radicals.PLoS One2011https://conductscience.org/library/papers/22140530PubMed
726983700Total peroxiredoxin expression is associated with survival in patients with follicular lymphoma.Virchows Arch2016https://conductscience.org/library/papers/26983700PubMed
828422070One Year Follow-Up Risk Assessment in SKH-1 Mice and Wounds Treated with an Argon Plasma Jet.Int J Mol Sci2017https://conductscience.org/library/papers/28422070PubMed
935159079Gas Plasma Exposure of Glioblastoma Is Cytotoxic and Immunomodulatory in Patient-Derived GBM Tissue.Cancers (Basel)2022https://conductscience.org/library/papers/35159079PubMed
1030355525Roles of intracellular and extracellular ROS formation in apoptosis induced by cold atmospheric helium plasma and X-irradiation in the presence of sulfasalazine.Free Radic Biol Med2018https://conductscience.org/library/papers/30355525PubMed
1135453677Cell Type-Specific Anti-Adhesion Properties of Peritoneal Cell Treatment with Plasma-Activated Media (PAM).Biomedicines2022https://conductscience.org/library/papers/35453677PubMed
1234766149Molecular mechanisms of chemo- and radiotherapy resistance and the potential implications for cancer treatment.MedComm (2020)2021https://conductscience.org/library/papers/34766149PubMed
1339620887Oxidative modifications control aberrant tyrosine kinase activity.Biointerphases2022https://conductscience.org/library/papers/39620887PubMed
1432231263Reactive oxygen species (ROS) as pleiotropic physiological signalling agents.Nat Rev Mol Cell Biol2020https://conductscience.org/library/papers/32231263PubMed
1539709737European consensus-based interdisciplinary guideline for melanoma. Part 2: Treatment - Update 2024.Eur J Cancer2025https://conductscience.org/library/papers/39709737PubMed
1625050490Cold atmospheric plasma treatment selectively targets head and neck squamous cell carcinoma cells.Int J Mol Med2014https://conductscience.org/library/papers/25050490PubMed
1719917871American Society of Clinical Oncology Clinical Practice Guideline update on chemotherapy for stage IV non-small-cell lung cancer.J Clin Oncol2009https://conductscience.org/library/papers/19917871PubMed
1819956595Electroporating fields target oxidatively damaged areas in the cell membrane.PLoS One2009https://conductscience.org/library/papers/19956595PubMed
1930031797Molecular targeted therapy: Treating cancer with specificity.Eur J Pharmacol2018https://conductscience.org/library/papers/30031797PubMed
2031455032Radiation as an In Situ Auto-Vaccination: Current Perspectives and Challenges.Vaccines (Basel)2019https://conductscience.org/library/papers/31455032PubMed

See all 263 referencesDownload CSV of references

Cited by4

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 3 citations.

PMIDTitleJournalYearIn PapersSource
42939890Small-Molecule Inhibitors Targeting Bacterial Antioxidants Potentiate Bactericidal Efficacy of Cold Atmospheric Plasma Against Staphylococcus aureus.Antioxidants (Basel)2026https://conductscience.org/library/papers/42939890PubMed
42788017Combined cold atmospheric plasma and vemurafenib suppress MITF-P21 signaling and MMP-driven metastasis in cutaneous melanoma.Iran J Basic Med Sci2026https://conductscience.org/library/papers/42788017PubMed
42036545Redox processes in the treatment of advanced skin cancers.Clin Exp Metastasis2026https://conductscience.org/library/papers/42036545PubMed
41898561Hydrogen Peroxide-Mediated Inhibition of Membrane Resealing Drives Synergistic Cytotoxicity of Combined Cold Atmospheric Plasma and Pulsed Electric Field Treatment.Int J Mol Sci2026https://conductscience.org/library/papers/41898561PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/41008962

GET https://conductscience.org/api/papers/v1/41008962/references?page=2